178 related articles for article (PubMed ID: 3116371)
61. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
Falk LA; Hogan MM; Vogel SN
J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
[TBL] [Abstract][Full Text] [Related]
62. Granules of human CD3+ large granular lymphocytes contain a macrophage regulating factor(s) that induces macrophage H2O2 production and tumoricidal activity but decreases cell surface Ia antigen expression.
Roussel E; Greenberg AH
Cell Immunol; 1991 Apr; 134(1):31-41. PubMed ID: 1826466
[TBL] [Abstract][Full Text] [Related]
63. Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity.
Boraschi D; Soldateschi D; Tagliabue A
Eur J Immunol; 1982 Apr; 12(4):320-6. PubMed ID: 6178603
[TBL] [Abstract][Full Text] [Related]
64. Lymphokine-mediated induction of cytolytic activity in a T cell hybridoma.
Kanagawa O; Chiller JM
J Immunol; 1985 Jan; 134(1):397-403. PubMed ID: 3917280
[TBL] [Abstract][Full Text] [Related]
65. Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon.
Akagawa KS; Tokunaga T
J Exp Med; 1985 Nov; 162(5):1444-59. PubMed ID: 2414387
[TBL] [Abstract][Full Text] [Related]
66. Macrophage-activating factors from different T cell clones induce distinct macrophage functions.
Gemsa D; Debatin KM; Kramer W; Kubelka C; Deimann W; Kees U; Krammer PH
J Immunol; 1983 Aug; 131(2):833-44. PubMed ID: 6190940
[TBL] [Abstract][Full Text] [Related]
67. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
68. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
69. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
70. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
Curley SA; Roh MS; Kleinerman E; Klostergaard J
Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
[TBL] [Abstract][Full Text] [Related]
71. Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharide.
de Weger RA; van Loveren H; de Groot JW; Rangarajan R; den Otter W
Immunobiology; 1986 Apr; 171(3):170-9. PubMed ID: 3486815
[TBL] [Abstract][Full Text] [Related]
72. Lead inhibits intracellular killing of Leishmania parasites and extracellular cytolysis of target cells by macrophages exposed to macrophage activating factor.
Mauël J; Ransijn A; Buchmüller-Rouiller Y
J Leukoc Biol; 1989 May; 45(5):401-9. PubMed ID: 2496192
[TBL] [Abstract][Full Text] [Related]
73. Cellular defenses against Toxoplasma gondii in newborns.
Wilson CB; Haas JE
J Clin Invest; 1984 Jun; 73(6):1606-16. PubMed ID: 6327765
[TBL] [Abstract][Full Text] [Related]
74. Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines.
Koff WC; Showalter SD; Chakrabarty MK; Hampar B; Ceccorulli LM; Kleinerman ES
J Leukoc Biol; 1985 Apr; 37(4):461-72. PubMed ID: 3882870
[TBL] [Abstract][Full Text] [Related]
75. IFN-gamma-induced production of monocyte cytotoxic factor.
Kildahl-Andersen O; Espevik T; Nissen-Meyer J
Cell Immunol; 1985 Oct; 95(2):392-406. PubMed ID: 3930074
[TBL] [Abstract][Full Text] [Related]
76. Role of lymphokines in regulation of macrophage differentiation.
Onozaki K; Akagawa KS; Haga S; Miura K; Hashimoto T; Tokunaga T
Cell Immunol; 1983 Feb; 76(1):129-36. PubMed ID: 6339080
[TBL] [Abstract][Full Text] [Related]
77. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
78. Lysis of inducer T cell clones by activated macrophages and macrophage-like cell lines.
Rao A; Faas SJ; Miller LJ; Riback PS; Cantor H
J Exp Med; 1983 Oct; 158(4):1243-58. PubMed ID: 6194244
[TBL] [Abstract][Full Text] [Related]
79. Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity.
Kleinerman ES; Fidler IJ
Lymphokine Res; 1983; 2(1):7-12. PubMed ID: 6381900
[No Abstract] [Full Text] [Related]
80. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
